Old College Capital is the in-house venture investment fund of the University of Edinburgh.
Portfolio
21
companies
Aveni
Aveni provides real time conversation analytics and automation tools for regulated industries.
Biocaptiva
Biocaptiva develops technology designed to improve liquid biopsy testing for cancer management.
Bioliberty
Bioliberty builds soft robotic gloves and digital therapy platforms for stroke rehabilitation.
Carcinotech
Carcinotech manufactures 3D printed tumours from cancer cells for oncology testing and research.
Concinnity Genetics
Concinnity Genetics builds artificial intelligence platforms to improve the safety of gene therapies.
Cytomos
Cytomos develops a proprietary cell analysis platform for the biopharma industry.
Forth Therapeutics
Forth Therapeutics develops next-generation precision treatments for fibrosis.
IONATE
IONATE builds the hardware and software backbone for smart electricity grids.
Invizius
Invizius develops treatments to prevent life threatening inflammation during dialysis.
Machines With Vision
Machines With Vision develops digital mapping and geolocation technology for railway maintenance.
Manus Neurodynamica
Manus Neurodynamica develops diagnostic technology for neuromotor disorders.
Mask Logic
Mask Logic manufactures custom fit reusable face masks using 3D scanning and printing technology.
MiAlgae
MiAlgae develops biotechnology to create sustainable Omega 3 from industry coproducts.
Mocean Energy
Mocean Energy develops wave energy technology to supply low-carbon power for marine environments.
Net AI
Net AI uses artificial intelligence and cloud computing to provide real-time demand insights for 5G network providers.
Neuranics
Neuranics develops advanced magnetic sensing technology to transform human machine interaction.
Singular Photonics
Developer of intelligent image sensors that count individual photons.
Sofant
Sofant builds radio frequency components and smart antenna solutions for wireless and satellite applications.
Sofant Technologies
Sofant Technologies develops low-power RF MEMS beamforming solutions for satellite communications.
VerbaFlo
VerbaFlo provides an AI communications platform for global real estate businesses.
Wobble Genomics
Wobble Genomics develops a novel approach to RNA sequencing for biotechnology applications.
Andrea Young
Fund Manager
The oversubscribed round will fund a next-generation sensor tape-out and team expansion following a surge in sales.
"We’ve already doubled our 2025 sales, we’re approaching break-even, and our customers are telling us exactly what they want from future product"
The seed round was led by Pi Labs to accelerate product development and international expansion.
"Real estate is one of the largest industries in the world, yet much of its revenue still depends on fragmented communication across channels. We built VerbaFlo to address this by creating a purpose-built vertical AI platform for residential real estate that integrates with the systems operators already use, enabling them to automate and optimise conversations across the resident lifecycle. Today, VerbaFlo supports more than 40 use cases across enquiry management, lead qualification, bookings, onboarding and resident engagement. We are incredibly proud to have the backing of Pi Labs alongside an exceptional group of investors, and this investment will accelerate product development and expand our presence across the UK, US and European markets."
The funding round was led by Archangels to support product development and market entry.
"Oncology is an exciting and vibrant sector. The scientists and technologists have been doing incredible things based upon the samples that they’re given, but there hasn’t been any particular movement in how the samples are prepared for years. Our msX platform has the potential to revolutionise how samples are collected, allowing for larger samples, faster extraction, simpler processing, and fully automatable capabilities."
The seed round was led by Blackfinch Ventures to support global growth and commercial adoption.
"This investment marks a significant step forward as we continue pioneering new applications for magnetic sensing. With the support of our investors, we are expanding our team, advancing our technology, and bringing our solutions closer to widespread adoption."
Equity Gap led the seed financing for the Edinburgh based manufacturer of custom fit respirators, with backing from Scottish Enterprise, Old College Capital, and Apollo Informal Investment.
"We realised that by combining modern 3D imaging with 3D-printed soft materials, we could create bespoke, perfectly fitted masks that conform to the unique contours of each face. In our first comparative trial, our masks proved more comfortable than standard disposable alternatives. Since then, we’ve refined our design dramatically yet we’ve remained true to our original mission: to create the most comfortable, personalised respiratory masks possible, suited for every face. We believe the days of painful, pressure-inducing masks are finally over."
